H2020-JTI-IMI2-2015-05-two-stage
H2020-JTI-IMI2-2015-05-two-stage
- Programme
- H2020
- Funded projects (dataset)
- 6
- EU contribution (sum)
- €47,476,823
- Portal deadline
- —
Leading topic in historical projects: IMI2-2015-05-01
Start here
Suggested partners for this call
Who coordinated consortia under this call, plus a complementary slice (topic leaders, research partners, or frequent non-coordinators). For industry lists, CSV export, and consortium size — open Proposal partner finder.
Top coordinators
Organisations that coordinated the most funded projects under this call.
- Fundacio ACE2 coordinated
- LUNDS UNIVERSITET1 coordinated
- STICHTING AMSTERDAM UMC1 coordinated
- UKB1 coordinated
- UU1 coordinated
Organisations strong on this topic
Broader signal: frequent participants across funded projects tagged with the same topic codes as this call (not limited to coordinators).
- ELI LILLY AND COMPANY LTD3 topic projects
- YAMANOUCHI EUROPE BROCADES PHARMA2 topic projects
- ASTRAZENECA AB2 topic projects
- BAYER AKTIENGESELLSCHAFT2 topic projects
- Bayer Pharma AG2 topic projects
- ROCHE2 topic projects
- JANSSEN PHARMACEUTICA NV2 topic projects
- SARD2 topic projects
- Universitätsklinikum Erlangen2 topic projects
- ABBV1 topic projects
- ABBVIE INC1 topic projects
- AbbVie1 topic projects
Frequent collaborators
Pairs that often appear together in the same funded project under this call.
- ELI LILLY AND COMPANY LTD · ASTRAZENECA AB3 shared
UK ↔ SE
- 2 shared
- ERASMUS MC · JANSSEN PHARMACEUTICA NV2 shared
NL ↔ BE
- JANSSEN PHARMACEUTICA NV · ASTRAZENECA AB2 shared
BE ↔ SE
- SARD · ELI LILLY AND COMPANY LTD2 shared
FR ↔ UK
- 2 shared
- JANSSEN PHARMACEUTICA NV · SARD2 shared
BE ↔ FR
- 2 shared
- 2 shared
- JANSSEN PHARMACEUTICA NV · ABBV2 shared
BE ↔ DE
- ROCHE · ELI LILLY AND COMPANY LTD2 shared
CH ↔ UK
- ROCHE · ASTRAZENECA AB2 shared
CH ↔ SE
- SARD · ASTRAZENECA AB2 shared
FR ↔ SE
- 2 shared
- 2 shared
- JANSSEN PHARMACEUTICA NV · ROCHE2 shared
BE ↔ CH
- JANSSEN PHARMACEUTICA NV · UKB2 shared
BE ↔ DE
- 2 shared
Proposal partner finder
One page with suggested coordinators, strong and industry partners, topic leaders, typical consortium size, similar projects — plus CSV or print / PDF export for your shortlist.
Typical consortium pattern
Derived from historical funded projects linked to this CORDIS call in Grantibase.
- Avg. orgs / project
- 23.67
- Median orgs / project
- 19
- Min / max orgs
- 14 – 38
Country presence
Participant rows (an org can appear in multiple countries if data varies).
- United Kingdom35
- Germany27
- Netherlands13
- Sweden11
- Belgium11
- Spain8
- Switzerland7
- Italy7
- Finland5
- France5
- United States4
- Luxembourg2
- Slovenia2
- Austria2
- Denmark2
- Ireland1
Organization types
- university44 orgs · 51 rows
- company33 orgs · 47 rows
- research_institute16 orgs · 20 rows
- sme15 orgs · 16 rows
- other5 orgs · 5 rows
- public_body2 orgs · 3 rows
Topics in funded projects
- IMI2-2015-05-01IMI2-2015-05-01· 1 projects
- IMI2-2015-05-02IMI2-2015-05-02· 1 projects
- IMI2-2015-05-03IMI2-2015-05-03· 1 projects
- IMI2-2015-05-04IMI2-2015-05-04· 1 projects
- IMI2-2015-05-05IMI2-2015-05-05· 1 projects
- IMI2-2015-05-06IMI2-2015-05-06· 1 projects
Related funded projects
Largest EU contributions in this call — useful to see who already won funding on similar lines.
Open full project list in advanced search
| Project | Programme | EU contribution |
|---|---|---|
| BEAt-DKD Biomarker Enterprise to Attack DKD - Sofia ref.: 115974 | H2020 | €15,085,937 |
| AMYPAD Amyloid imaging to Prevent Alzheimer’s Disease – Sofia ref.: 115952 | H2020 | €11,999,886 |
| PHAGO Inflammation and AD: modulating microglia function focussing on TREM2 and CD33 - Sofia ref.: 115976 | H2020 | €8,838,000 |
| PREFER Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 | H2020 | €6,000,000 |
| ADAPTED Alzheimers Disease Apolipoprotein Pathology for Treatment Elucidation and Development - Sofia ref.: 115975 | H2020 | €3,510,000 |
| MOPEAD Models Of Patient Engagement for Alzheimer’s Disease - Sofia ref.: 115985 | H2020 | €2,043,000 |